SE335359B - - Google Patents

Info

Publication number
SE335359B
SE335359B SE14182/66A SE1418266A SE335359B SE 335359 B SE335359 B SE 335359B SE 14182/66 A SE14182/66 A SE 14182/66A SE 1418266 A SE1418266 A SE 1418266A SE 335359 B SE335359 B SE 335359B
Authority
SE
Sweden
Application number
SE14182/66A
Inventor
K Wetterlin
L Svensson
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE14182/66A priority Critical patent/SE335359B/xx
Priority to AT09420/69A priority patent/AT287678B/de
Priority to AT915967A priority patent/AT286964B/de
Priority to AT941969A priority patent/AT288356B/de
Priority to AT09421/69A priority patent/AT287679B/de
Priority to BE704932D priority patent/BE704932A/xx
Priority to CH323870A priority patent/CH510626A/de
Priority to CH324070A priority patent/CH510627A/de
Priority to CH1425567A priority patent/CH510625A/de
Priority to CH323970A priority patent/CH512428A/de
Priority to ES346131A priority patent/ES346131A1/es
Priority to FR124741A priority patent/FR8011M/fr
Priority to DE1793759A priority patent/DE1793759C3/de
Priority to DE1643296A priority patent/DE1643296C3/de
Priority to NO170180A priority patent/NO120686B/no
Priority to DK518567AA priority patent/DK128491B/da
Priority to GB47505/67A priority patent/GB1199630A/en
Priority to FI672811A priority patent/FI50786C/fi
Priority to NL676714191A priority patent/NL151693B/xx
Priority to ES361429A priority patent/ES361429A1/es
Priority to ES361432A priority patent/ES361432A1/es
Priority to ES361431A priority patent/ES361431A1/es
Priority to ES361433A priority patent/ES361433A1/es
Priority to NO302670A priority patent/NO132866C/no
Publication of SE335359B publication Critical patent/SE335359B/xx
Priority to DK285571A priority patent/DK135577B/da
Priority to US05/372,497 priority patent/US3937838A/en
Priority to FI218673A priority patent/FI50788C/fi
Priority to FI218573A priority patent/FI54798C/fi
Priority to NL7513854A priority patent/NL7513854A/xx
Priority to DK468876A priority patent/DK468876A/da
Priority to IT8048168A priority patent/IT8048168A0/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/48—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation involving decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE14182/66A 1966-10-19 1966-10-19 SE335359B (is)

Priority Applications (31)

Application Number Priority Date Filing Date Title
SE14182/66A SE335359B (is) 1966-10-19 1966-10-19
AT09420/69A AT287678B (de) 1966-10-19 1967-10-10 Verfahren zur herstellung von neuen 1-(3',5'-dihydroxy-bzw. -acyloxy-phenyl)-2-alkylamino-aethanolen und deren physiologisch vertraeglichen saeureadditionssalzen
AT915967A AT286964B (de) 1966-10-19 1967-10-10 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-alkylaminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
AT941969A AT288356B (de) 1966-10-19 1967-10-10 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-alkylaminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
AT09421/69A AT287679B (de) 1966-10-19 1967-10-10 Verfahren zur herstellung von neuen 1-(3',5'-dihydroxy-bzw. -acyloxyphenyl)-2-cyclobutylaminoaethanolen und deren physiologisch vertraeglichen saeureadditionssalzen
BE704932D BE704932A (is) 1966-10-19 1967-10-11
CH323870A CH510626A (de) 1966-10-19 1967-10-12 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
CH324070A CH510627A (de) 1966-10-19 1967-10-12 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxyphenyl)-2-cyclobutylaminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
CH1425567A CH510625A (de) 1966-10-19 1967-10-12 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
CH323970A CH512428A (de) 1966-10-19 1967-10-12 Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen
ES346131A ES346131A1 (es) 1966-10-19 1967-10-16 Procedimiento para la preparacion de compuestos efectivos en el tratamiento de condiciones broncospaticas.
FR124741A FR8011M (is) 1966-10-19 1967-10-17
DE1793759A DE1793759C3 (de) 1966-10-19 1967-10-17 H3',5'-Dihydroxyphenyl)-2-(lmethylcyclobutylamino)-äthanol und dessen physiologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE1643296A DE1643296C3 (de) 1966-10-19 1967-10-17 l-Aryl-2-alkylaminoäthanole und deren physiologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DK518567AA DK128491B (da) 1966-10-19 1967-10-18 Analogifremgangsmåde til fremstilling af en eventuelt esterificeret 1-(3',5'-dihydroxyphenyl)-2-(t-butylamino)- eller -2-(cyclobutylamino)-ethanol eller syreadditionssalte heraf eller de tilsvarende optisk aktive forbindelser.
NO170180A NO120686B (is) 1966-10-19 1967-10-18
GB47505/67A GB1199630A (en) 1966-10-19 1967-10-18 Phenylethanolamine Derivatives Effective in the Treatment of Bronchospastic Conditions
FI672811A FI50786C (fi) 1966-10-19 1967-10-19 Analogiamenetelmä suun kautta annettavien, bronkospasmolyyttisesti vai kuttavien 1-(3,5-dihyrdoksifenyyli)-2-(tert.-butyyliamino)etanolien ja niiden estereiden valmistamiseksi.
NL676714191A NL151693B (nl) 1966-10-19 1967-10-19 Werkwijze voor het bereiden van een geneesmiddel met een bronchospasmolytische werking dat een derivaat van 2-amino-1-(3,5-dihydroxyfenyl)ethanol bevat en het onder toepassing van deze werkwijze verkregen gevormde geneesmiddel met een bronchospasmolytische werking en werkwijze voor het bereiden van een geneeskrachtig 2-amino-1-(3,5-dihydroxyfenyl)ethanolderivaat, dat als actief bestanddeel in zo'n geneesmiddel wordt toegepast.
ES361429A ES361429A1 (es) 1966-10-19 1968-12-14 Procedimiento para la preparacion de compuestos efectivos en el tratamiento de condiciones broncospaticas.
ES361432A ES361432A1 (es) 1966-10-19 1968-12-14 Un metodo para el tratamiento de condiciones broncospaticasen animales, con inclusion del hombre.
ES361431A ES361431A1 (es) 1966-10-19 1968-12-14 Procedimiento para la preparacion de compuestos efectivos en el tratamiento de condiciones broncospaticas.
ES361433A ES361433A1 (es) 1966-10-19 1968-12-14 Procedimiento de obtencion de preparados farmaceuticos parael tratamiento de condiciones broncospasticas.
NO302670A NO132866C (is) 1966-10-19 1970-08-05
DK285571A DK135577B (da) 1966-10-19 1971-06-11 Substitueret omega-amino-acetophenon til anvendelse som mellemprodukt ved fremstilling af 3,5-disubstituerede phenylethanolaminforbindelser eller syreadditionssalte heraf.
US05/372,497 US3937838A (en) 1966-10-19 1973-06-21 Orally active bronchospasmolytic compounds and their preparation
FI218673A FI50788C (fi) 1966-10-19 1973-07-09 Menetelmä valmistaa bronkospasmolyyttisesti aktiivinen 1-(31,51-dihydr oksifenyyli)-2-syklobutyyliaminoetanoli sekä sen 31,51-diasyloidut joh dannaiset
FI218573A FI54798C (fi) 1966-10-19 1973-07-09 Substituerad omega-amino-acetofenon avsedd att anvaendas saosom utgaongsmaterial vid framstaellning av bronkospasmolytiska foereningar
NL7513854A NL7513854A (nl) 1966-10-19 1975-11-27 Werkwijze voor het bereiden van een geneesmiddel met bronchospasmolytische werking dat een of een aantal derivaten van 2-amino-1-(3,5-dihydroxyfenyl)- -ethanol bevat en de onder toepassing van deze werkwij- ze verkregen gevormde geneesmiddelen met bronchospasmo- lytyische werking en werkwijze voor het bereiden van ge-neeskrachtige 2-amino-1-(3,5-dihydroxyfenyl)-ethanol- derivaten.
DK468876A DK468876A (da) 1966-10-19 1976-10-18 Mellemprodukt til anvendelse ved fremstilling af 3,5-disubstituerede phenylethanolaminforbindelser eller syreadditionssalte heraf
IT8048168A IT8048168A0 (it) 1966-10-19 1980-03-14 Composti farmaceutici per il trattamento di condizioni broncospastiche e procedimento di preparazione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE14182/66A SE335359B (is) 1966-10-19 1966-10-19

Publications (1)

Publication Number Publication Date
SE335359B true SE335359B (is) 1971-05-24

Family

ID=20298669

Family Applications (1)

Application Number Title Priority Date Filing Date
SE14182/66A SE335359B (is) 1966-10-19 1966-10-19

Country Status (13)

Country Link
AT (4) AT287679B (is)
BE (1) BE704932A (is)
CH (1) CH510625A (is)
DE (2) DE1643296C3 (is)
DK (2) DK128491B (is)
ES (5) ES346131A1 (is)
FI (1) FI50786C (is)
FR (1) FR8011M (is)
GB (1) GB1199630A (is)
IT (1) IT8048168A0 (is)
NL (2) NL151693B (is)
NO (1) NO120686B (is)
SE (1) SE335359B (is)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419364A (en) 1980-07-09 1983-12-06 Aktiebolaget Draco Bronchospasmolytic carbamate derivatives

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138581A (en) 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
CY1271A (en) * 1980-07-09 1985-03-08 Draco Ab Therapeutically active derivatives of phenylethanol amines
US4853381A (en) * 1984-04-17 1989-08-01 Glaxo Group Limited Ethanolamine compounds
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
EP0213108A3 (de) * 1985-06-26 1987-07-15 Kurt Dr. Burghart Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
WO2013081565A1 (en) 2011-11-21 2013-06-06 Mahmut Bilgic Pharmaceutical compositions comprising roflumilast and terbutaline
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
WO2018182546A1 (en) 2017-03-27 2018-10-04 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
CN110057932B (zh) * 2019-04-22 2022-03-15 上海旭东海普药业有限公司 高效液相色谱分析硫酸特布他林有关物质的方法
CN111440078A (zh) * 2020-04-26 2020-07-24 梯尔希（南京）药物研发有限公司 特布他林衍生物的制备方法
CN113264839B (zh) * 2021-04-27 2022-08-30 苏州弘森药业股份有限公司 一种使用手性辅基制备左旋特布他林的方法
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419364A (en) 1980-07-09 1983-12-06 Aktiebolaget Draco Bronchospasmolytic carbamate derivatives

Also Published As

Publication number Publication date
FI50786C (fi) 1976-07-12
DE1793759B2 (de) 1978-05-11
AT287678B (de) 1971-02-10
DE1793759C3 (de) 1979-01-11
NL6714191A (is) 1968-04-22
DE1643296B2 (de) 1973-10-25
DE1793759A1 (de) 1973-08-16
DE1643296C3 (de) 1974-06-12
CH510625A (de) 1971-07-31
DK468876A (da) 1976-10-18
ES361431A1 (es) 1970-11-01
AT286964B (de) 1971-01-11
GB1199630A (en) 1970-07-22
NL7513854A (nl) 1976-03-31
ES361433A1 (es) 1970-11-01
NO120686B (is) 1970-11-23
NL151693B (nl) 1976-12-15
ES361432A1 (es) 1970-11-01
ES346131A1 (es) 1969-05-16
FI50786B (is) 1976-03-31
DK128491B (da) 1974-05-13
IT8048168A0 (it) 1980-03-14
AT288356B (de) 1971-03-10
AT287679B (de) 1971-02-10
DE1643296A1 (de) 1971-09-30
BE704932A (is) 1968-02-15
ES361429A1 (es) 1970-11-01
FR8011M (is) 1970-07-27

Similar Documents

Publication Publication Date Title
FR8011M (is)
AU5917865A (is)
AU428063B2 (is)
AU424443B2 (is)
AU414526B2 (is)
AU433222B2 (is)
AU421822B2 (is)
AU417216B2 (is)
AU415165B1 (is)
AU1144366A (is)
AU6703465A (is)
AU612166A (is)
AU1111066A (is)
AU5895065A (is)
AU218666A (is)
BE447356A (is)
BE618801A (is)
AU2390066A (is)
AU407778B2 (is)
AU415780B2 (is)
BE637138A (is)
AU411645B2 (is)
AU6852465A (is)
AU855865A (is)
AU92366A (is)